The number of Danes who died from cardiovascular disease has fallen by 70% between 1985 and 2009. No EU member state has a recorded a greater decline in mortality. A ban on trans fat acids in 2003 could be the cause.
46% of all deaths in Europe are caused by cardiovascular disease, making it Europe's biggest killer.
Miami-based medical technology company with an R&D subsidiary in Moshav Ora, near Jerusalem, has developed an easy, non-invasive method to detect breast cancer early on – using a simple blood test.
In its laboratories near the capital, Eventus Diagnostics (EventusDx) has developed what it describes as an accurate, cost-effective, immune system-based means of detecting the presence of cancer in the breast tissue.
The Octava tests, which measure cancer-specific antibodies produced by the immune system in response to the growth of tumors, can be used to quickly diagnose breast cancer and identify false negative mammogram results.
SOLS, a 3D-printing company which is today focused on custom printed shoe insoles that help with foot pain and other ailments, has raised $6.4 million in Series A funding, in a round again led by the startup’s seed investor lead, Lux Capital. In addition, new investor Founders Fund also participated, along with existing investors RRE, Rothenberg Ventures, Felicis Ventures, FundersGuild, and Grape Arbor VC.
Here’s a not-so-sweet fact: According to the American Diabetes Association, one in three American adults will be diagnosed with diabetes by the year 2050 if present trends continue. The disturbing possibility of such a widespread phnomenon is what motivated two Israeli researchers to seek out more effective methods of treating and detecting the forthcoming high blood sugar epidemic.
Both Dr. Eli Lewis of Ben Gurion University and Dr. Nataly Lerner of Tel Aviv University’s Sackler Faculty of Medicine made recent breakthroughs individually, first in the treatment of Type I diabetes, or juvenile diabetes, then in the early detection of Type II diabetes, or adult-onset diabetes, using a blood test (respectively).
In the last few years tech companies have jumped on the wearable tech bandwagon with popular gadgets like the Fitbit or Samsung’s Gear Fit. There are also hundreds of fitness apps taking the smartphone world by storm. The importance of health technologies is becoming more prevalent as everyone, from athletes to housewives, have realised the need to track calories and steps using an app or a wristband.
Israel’s start-up community has gained wide recognition mainly because of entrepreneurs in the areas of communications, software, Internet and social media. Waze, a GPS application, made news because Google paid more than $1 billion for it. Trusteer — cyber security software — made similar headlines when IBM bought it for a similar sum.
Although they disproportionately affect young people and impact many lives negatively, allergies are still neglected by medical specialists and few countries have adequate programmes in place to deal with them, writes Claudio Ciprian Tănăsescu.
Claudiu Ciprian Tănăsescu is a Romanian MEP in the S&D group and a member of the Environment, Public Health and Food Safety Committee in the European Parliament.
What are allergies? An allergy is defined as an exaggerated response of the human immune system to substances that should be harmless. While these may be manageable for some people, for many others they can have a serious impact on their lives.
The tradition of predicting flu and tracking disease outbreaks has tended to fall exclusively on the shoulders of the Centers for Disease Control. Healthcare entrepreneurs have sought to supplement that info by using big data generated from social media channels such as Twitter to make assessments earlier. A new study by a couple of researchers at Boston Children’s Hospital identifies another website which could be used for this task: Wikipedia.
Influenza is attributed to up to 500,000 deaths each year globally, with up to 3,500 in the U.S. alone.
Les chercheurs de l'Université de Tel Aviv mettent à profit les nanotechnologies pour attaquer les tumeurs de l'ovaire, particulièrement résistantes aux traitements médicaux classiques.
Le cancer de l'ovaire
Le cancer de l'ovaire touche plusieurs milliers de femmes chaque année en France (4375 en 2005). Il représente 3,2% des cancers féminins. La mortalité due à cette maladie est de 4,6/100.000 femmes, sachant que l'incidence (nombre de femmes touchées) est de 8,1/100.000.
Though Europeans’ life expectancies are increasing, a growing number of elederly people is also experiencing more years living with a chronic disease, which is a big challenge for future societies.
At the EU’s summit on chronic diseases (3 April), member states shared good examples, initiatives and best practices to illustrate how to tackle chronic diseases when the number of cases rise.
